Duration of Protection: GSK DTaP Vaccines

Clinical trial NCT02447978 · COMPLETED

Trial details

NCT number: NCT02447978
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Diphtheria Acellular Pertussis Tetanus

Start date: 2015-02-01
Primary completion: 2015-06-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.